As of 2024-12-12, the Relative Valuation of Veracyte Inc (VCYT) is (2.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 43.51 USD, the upside of Veracyte Inc based on Relative Valuation is -106.3%.
The range of the Relative Valuation is (2.24) - (2.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 34.7x | 26.5x |
| Forward P/E multiples | 18.7x - 20.5x | 19.6x |
| Fair Price | (2.24) - (2.45) | (2.76) |
| Upside | -105.1% - -105.6% | -106.3% |
| Date | P/E |
| 2024-12-10 | -359.40 |
| 2024-12-09 | -357.56 |
| 2024-12-06 | -369.02 |
| 2024-12-05 | -358.23 |
| 2024-12-04 | -368.69 |
| 2024-12-03 | -365.09 |
| 2024-12-02 | -368.94 |
| 2024-11-29 | -359.15 |
| 2024-11-27 | -358.65 |
| 2024-11-26 | -358.23 |
| 2024-11-25 | -343.68 |
| 2024-11-22 | -331.06 |
| 2024-11-21 | -325.62 |
| 2024-11-20 | -327.79 |
| 2024-11-19 | -327.38 |
| 2024-11-18 | -306.97 |
| 2024-11-15 | -300.53 |
| 2024-11-14 | -309.73 |
| 2024-11-13 | -330.55 |
| 2024-11-12 | -319.77 |
| 2024-11-11 | -325.20 |
| 2024-11-08 | -305.05 |
| 2024-11-07 | -312.24 |
| 2024-11-06 | -305.97 |
| 2024-11-05 | -300.45 |
| 2024-11-04 | -292.51 |
| 2024-11-01 | -286.90 |
| 2024-10-31 | -282.14 |
| 2024-10-30 | -292.67 |
| 2024-10-29 | -287.49 |
| 2024-10-28 | -285.32 |
| 2024-10-25 | -276.20 |
| 2024-10-24 | -274.11 |
| 2024-10-23 | -271.35 |
| 2024-10-22 | -272.60 |
| 2024-10-21 | -276.95 |
| 2024-10-18 | -287.99 |
| 2024-10-17 | -286.90 |
| 2024-10-16 | -290.33 |
| 2024-10-15 | -284.90 |
| 2024-10-14 | -283.73 |
| 2024-10-11 | -284.48 |
| 2024-10-10 | -269.85 |
| 2024-10-09 | -266.92 |
| 2024-10-08 | -279.96 |
| 2024-10-07 | -283.22 |
| 2024-10-04 | -274.61 |
| 2024-10-03 | -275.70 |
| 2024-10-02 | -282.60 |
| 2024-10-01 | -277.04 |